Rifaximin Prevents Overt Hepatic Encephalopathy After TIPS
For patients with cirrhosis, rifaximin reduces odds of overt HE after transjugular intrahepatic portosystemic shunt
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.